Physician profile
Michael Mcgeagh
NPI 1306423843
$1,039.64
in general payments reported to CMS, 2019-2025
17 companies · $739 in 2025
The $739 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $301 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $230.75 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $156.78 | 2024-2025 | |
| Saluda Medical Americas, INC. | $131.33 | 2024 | Evoke |
| Astrazeneca Pharmaceuticals LP | $121.82 | 2025 | Breztri |
| Tolmar, INC. | $63.93 | 2025 | Jatenzo |
| Pfizer INC. | $63.08 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $58.69 | 2024-2025 | Spravato |
| Lilly USA, LLC | $33.99 | 2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $32.75 | 2024 | Gardasil, Gardasil 9, M-M-R II |
| Kyowa Kirin, INC. | $22.09 | 2025 | |
| Exact Sciences Corporation | $20.84 | 2025 | Cologuard Collection Kit |
| Viiv Healthcare Company | $20.45 | 2025 | Apretude |
| Phadia US INC. | $20.29 | 2024 | Immunocap |
| Dexcom, INC. | $16.80 | 2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.10 | 2024 | Caplyta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $15.60 | 2025 | Shingrix, Arexvy |
| Otsuka America Pharmaceutical, INC. | $14.35 | 2025 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcgeagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.